PE-backed spine company shoots for 2022 FDA approval

Alan Condon -   Print  |

SHS Capital has invested in Blue Ocean Spine, a Germany-based device company seeking to expand into the U.S. in 2022.

Blue Ocean Spine is developing spinal cages that eliminate additional screw connections for surgeons, according to a Jan. 12 news release. The company aims to limit the number of implants required in the operating room and streamline surgeon workflow.

The implants are manufactured using 3D printing, which can provide greater cost savings over other implant materials.

SHS Capital, a German company that focuses on venture capital and private equity investments, will "assist Blue Ocean Spine with equity and our broad network," Patrick Frohnheiser, investment manager at SHS Capital, said in the news release.

More articles on devices:
Medtronic CEO predicts AI, machine learning as 'the new frontier for medtech' — 4 key quotes
40 orthopedic devices receiving FDA clearance in December
Stryker, Smith+Nephew seal 1st acquisitions of 2021: 7 device company notes

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers